APC and neoplasm: The AhCre+Apcfl/+ tumour model was used in our short-term cohorts as this model develops tumours at a similar latency to that of the ApcMin/+ model, inducing Apc deletion at a fixed time point provides experimental consistency and Apc remains intact within the immune system.